EPCAM and neoplasm: Importantly, tumor fragments derived from CD133+/EpCAM+ tumor spheroid cells, but not from CD133−/EpCAM+ differentiated cells, demonstrated continual growth potential after re-implantation in the secondary mice (Fig. 4B).